Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence?

Literature DB >> 23415261

Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence?

Ravi Mangal Patel¹, Patricia Wei Denning.

Abstract

Necrotizing enterocolitis (NEC) is a leading cause of neonatal morbidity and mortality, and preventive therapies that are both effective and safe are urgently needed. Current evidence from therapeutic trials suggests that probiotics are effective in decreasing NEC in preterm infants, and probiotics are currently the most promising therapy for this devastating disease. However, concerns regarding safety and optimal dosing have limited the widespread adoption of routine clinical use of probiotics in preterm infants. This article summarizes the current evidence regarding the use of probiotics, prebiotics, and postbiotics in the preterm infant, including their therapeutic role in preventing NEC.

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：
Prebiotics

Year: 2013 PMID： 23415261 PMCID： PMC3575601 DOI： 10.1016/j.clp.2012.12.002

Source DB: PubMed Journal: Clin Perinatol ISSN： 0095-5108 Impact factor: 3.430

98 in total

1. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.

Authors: A S Neish; A T Gewirtz; H Zeng; A N Young; M E Hobert; V Karmali; A S Rao; J L Madara
Journal: Science Date: 2000-09-01 Impact factor: 47.728

2. Intestinal permeability in relation to birth weight and gestational and postnatal age.

Authors: R M van Elburg; W P F Fetter; C M Bunkers; H S A Heymans
Journal: Arch Dis Child Fetal Neonatal Ed Date: 2003-01 Impact factor: 5.747

3. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial.

Authors: F N Sari; E A Dizdar; S Oguz; O Erdeve; N Uras; U Dilmen
Journal: Eur J Clin Nutr Date: 2011-01-19 Impact factor: 4.016

4. Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial.

Authors: H Kitajima; Y Sumida; R Tanaka; N Yuki; H Takayama; M Fujimura
Journal: Arch Dis Child Fetal Neonatal Ed Date: 1997-03 Impact factor: 5.747

5. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis.

Authors: Vanaja N Alexander; Veronika Northrup; Matthew J Bizzarro
Journal: J Pediatr Date: 2011-04-13 Impact factor: 4.406

6. Factors influencing the composition of the intestinal microbiota in early infancy.

Authors: John Penders; Carel Thijs; Cornelis Vink; Foekje F Stelma; Bianca Snijders; Ischa Kummeling; Piet A van den Brandt; Ellen E Stobberingh
Journal: Pediatrics Date: 2006-08 Impact factor: 7.124

7. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis.

Authors: Susan R Hintz; Douglas E Kendrick; Barbara J Stoll; Betty R Vohr; Avroy A Fanaroff; Edward F Donovan; W Kenneth Poole; Martin L Blakely; Linda Wright; Rosemary Higgins
Journal: Pediatrics Date: 2005-03 Impact factor: 7.124

8. The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddylation.

Authors: Amrita Kumar; Huixia Wu; Lauren S Collier-Hyams; Young-Man Kwon; Jason M Hanson; Andrew S Neish
Journal: J Immunol Date: 2009-01-01 Impact factor: 5.422

9. The relationship of neonatal alimentation practices to the occurrence of endemic necrotizing enterocolitis.

Authors: D M Anderson; R M Kliegman
Journal: Am J Perinatol Date: 1991-01 Impact factor: 1.862

Review 10. The butyrate story: old wine in new bottles?

Authors: Wolfgang Scheppach; Frank Weiler
Journal: Curr Opin Clin Nutr Metab Care Date: 2004-09 Impact factor: 4.294

41 in total

1. Routine Supplementation of Lactobacillus rhamnosus GG and Risk of Necrotizing Enterocolitis in Very Low Birth Weight Infants.

Authors: Andrea F Kane; Anisha D Bhatia; Patricia W Denning; Andi L Shane; Ravi Mangal Patel
Journal: J Pediatr Date: 2018-04 Impact factor: 4.406

Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence?

1. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.

2. Intestinal permeability in relation to birth weight and gestational and postnatal age.

3. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial.

4. Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial.

5. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis.

6. Factors influencing the composition of the intestinal microbiota in early infancy.

7. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis.

8. The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddylation.

9. The relationship of neonatal alimentation practices to the occurrence of endemic necrotizing enterocolitis.

Review 10. The butyrate story: old wine in new bottles?

1. Routine Supplementation of Lactobacillus rhamnosus GG and Risk of Necrotizing Enterocolitis in Very Low Birth Weight Infants.

Review 2. Intestinal microbiota and its relationship with necrotizing enterocolitis.

Review 3. One size will never fit all: the future of research in pediatric transfusion medicine.

Review 4. Probiotics and necrotizing enterocolitis.

Review 5. Biodiversity of Intestinal Lactic Acid Bacteria in the Healthy Population.

Review 6. [Research progress of the application of probiotics in preterm infants].

Review 7. To start or not: Factors to consider when implementing routine probiotic use in the NICU.

8. Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation.

9. Effect of bacteriocin and exopolysaccharides isolated from probiotic on P. aeruginosa PAO1 biofilm.

Review 10. Microbial therapeutic interventions.